Clinical Trials Logo

Signs and Symptoms clinical trials

View clinical trials related to Signs and Symptoms.

Filter by:

NCT ID: NCT01675960 Terminated - Chronic Pain Clinical Trials

Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

Start date: April 2012
Phase: Phase 2
Study type: Interventional

This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources.

NCT ID: NCT01634958 Completed - Dose-Finding Study Clinical Trials

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Start date: October 2012
Phase: Phase 2
Study type: Interventional

Specific immunotherapy for IgE mediated sensitization to grass pollen 4 concentrations of a modified pollen extract of Phleum pratense are applied to find out the optimum dose.

NCT ID: NCT01631461 Completed - Breast Infection Clinical Trials

Painful Breastfeeding and Bacterial or Yeast Infection

Start date: December 2006
Phase: N/A
Study type: Observational

The aim of this study is to investigate the prevalence of yeast and bacteria in women with breastfeeding pain and to identify signs and symptoms.

NCT ID: NCT01586676 Completed - Signs and Symptoms Clinical Trials

Effectiveness of Motivational Interviewing Supervision in Community Programs

Start date: January 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The virtual requirement that substance abuse programs use evidence-based treatments (EBT) has prompted the development of dissemination strategies to promote EBT technology transfer. Implementation research, clinical trial training methods, and clinician training studies suggest that clinical supervision that involves direct observation, fidelity rating-based feedback, and coaching of therapeutic skills is a promising dissemination approach. However, clinical supervision delivered within substance abuse programs by on-site supervisors has never been directly tested in a randomized controlled trial to determine the impact of supervision on both clinician EBT skills and client treatment outcomes. Recent results from two NIDA CTN protocols testing the effectiveness of Motivational Interviewing (MI) have shown that community program clinicians can learn to deliver MI with fidelity when receiving MI supervision from their program supervisors after workshop training and that their implementation of MI early in treatment improves client retention and primary substance use outcomes. A MI supervision manual called MIA: STEP (Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency) was developed from these protocols and has begun to be widely distributed by NIDA in partnership with SAMHSA for community program use. The effectiveness of the MIA: STEP supervision approach is unknown. This study will directly test the effectiveness of MIA: STEP supervision on clinician MI fidelity and on client outcomes by randomly assigning 60 clinicians and 420 substance-using outpatients from 11 community programs within Connecticut to one of two conditions in which clinicians in both conditions will deliver a 1-session MI intervention to clients as the enter treatment. The conditions are: 1) workshop training plus MIA: STEP supervision, and 2) workshop training alone with supervision-as-usual practices used at each program. This project will be the first randomized trial to examine the impact of clinical supervision in an empirically based treatment on both clinician and client outcomes. Moreover, because it will provide workshop training and supervision completely within the context of community programs and utilize in-house program supervisors, it will provide a rigorous evaluation of a feasible model for disseminating EBTs such as MI.

NCT ID: NCT01558206 Enrolling by invitation - Clinical trials for Pulmonary Thromboembolism

Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE

Start date: March 2012
Phase: N/A
Study type: Observational

In this study the investigators compare the diagnostic validity of Bedside Ultrasonography of chest and Pulmonary artery CT Angiography in the patients who came to Emergency Department of Alzahra General Hospital from 1 may 2012 to 1 October 2012 with respiratory symptoms and signs in favor of Pulmonary Thromboemboli (PTE).

NCT ID: NCT01551238 Recruiting - Obesity Clinical Trials

Energy Expenditure, Sleep and Macronutrients

Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine energy expenditure and sleep in response to protein/carbohydrate and fat ratio of the diet over a short-term and long-term period of time.

NCT ID: NCT01532180 Completed - Clinical trials for Sleep Apnea, Obstructive

Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)

Start date: November 2009
Phase: N/A
Study type: Interventional

The objective of the study is to determine the safety and preliminary efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).

NCT ID: NCT01483703 Completed - Signs and Symptoms Clinical Trials

Noninvasive Optical Measurement of Critical Care Neonates

Start date: May 2010
Phase:
Study type: Observational

The purpose of this study is to determine whether reflections of light can be used to provide real-time pictures of blood vessel formation around infants' heads. This study device is called laser speckle imaging.

NCT ID: NCT01483495 Completed - Signs and Symptoms Clinical Trials

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study

DOSI
Start date: December 2011
Phase:
Study type: Observational

The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of the body.

NCT ID: NCT01464814 Recruiting - Clinical trials for Signs and Symptoms, Digestive

Clinical Trial Evaluating the Viability of L. Casei + Fish Oil Capsules

Probiomega
Start date: October 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of the probiotic KE-99 Lactobacillus casei when administered with omega-3 fish oil on probiotic viability, fecal make-up and gastrointestinal (GI) health in healthy adults.